Injectable Peptides and Oral Alternatives

Peptides are having a moment. 

Features on The Ultimate Human podcast, Huberman Lab, and more are educating consumers on the benefits. Meanwhile, clinicians are introducing more and more patients to cutting-edge treatments. 

But there’s an issue. 

People don’t like needles. 

And since peptides break down in the digestive tract, the most common delivery mechanism is a needle. 

In this article, we’ll discuss how supplement brand founders can capitalize by delivering peptides in ways people actually want to take. 

What’s Behind the Peptide Moment?

Peptides are popular for their consumer-related benefits of tissue-healing, repair, and muscle-growth-enhancing properties.

“I think some peptides are going to be as common as multivitamins in as little as five years,” says Gary Brecka, biologist and founder of The Ultimate Human health and wellness brand. 

That might sound bold, but when you look at how quickly the peptide conversation moved from niche clinics and performance circles to mainstream podcasts and everyday health conversations, it starts to feel less like hype and more like early-stage adoption. 

But how do they work?

Peptides — short amino acid chains — exist in the body naturally. And where traditional supplements provide nutrients and ingredients that benefit the body, peptides are tiny messengers that tell your body what to do with what’s already there:

“Repair this tissue.”

“Release more of this hormone.”

“Calm this inflammatory response.” 

When we inject peptides, we’re essentially walking a letter directly into your body’s mailbox. Rather than waiting on the postal service to deliver, we skip the line, avoid the harsh digestive acids that may destroy it along the way, and deliver a molecule that fits your body’s receptors like a key to a lock.

Why Inject Instead of Taking a Pill?

The simple answer is most peptides don't survive digestion. When ingested orally, your body treats them like proteins. Stomach acids and enzymes break them into smaller pieces, disintegrating the original structure and any message they may carry along the way.

Injections bypass that problem by delivering peptides directly into circulation. From a clinical perspective, it's the most efficient route — but it comes with real tradeoffs. Needles are a barrier for most consumers. Many injectable peptides aren't FDA approved. And the regulatory environment around them continues to evolve, with the FDA tightening restrictions on what compounding pharmacies can dispense.

For the supplement industry, injectables aren't really the conversation. They live in a clinical and gray-market world that most brands can't — and shouldn't — try to operate in.

Popular Injectable Peptides (And Why They're Driving the Conversation)

To understand where the consumer interest is coming from, it helps to know what's being talked about in clinics and on podcasts:

• BPC-157: Originally identified in proteins found in human gastric juice. Known in clinical circles for tissue repair in tendons, muscles, and ligaments.
• TB-500: A synthetic version of Thymosin Beta-4. Associated with soft tissue repair and recovery.
• CJC-1295: Designed to stimulate natural growth hormone and IGF-1 production. Used in anti-aging and recovery protocols.

None of these are FDA approved supplements. But the conversation around them has created enormous consumer curiosity around what peptides do — signaling the body to repair, recover, and perform better at the cellular level.

That's the real opportunity for supplement brands. Not chasing the injectable category, but meeting the demand it's created with products that are safe, legal, clinically backed, and orally bioavailable.

The Real Opportunity: Oral Peptides That Actually Work

Here's what most of the industry misses. The injectable conversation made consumers fluent in the word "peptide." But the next wave of growth isn't in needles. It's in plant-derived, clinically studied peptides that survive digestion and signal the same pathways consumers are already asking about.

Nuritas is leading that wave. Using an AI-powered discovery platform, they've identified specific cell-signaling peptides from plants — peptides that hit the same biological targets as the injectables driving headlines, but in a format your customer can actually take with breakfast.

Two ingredients stand out for brands building in this space.

PeptiStrong™ — Plant Peptides for Muscle Recovery and Strength

PeptiStrong is a fava bean-derived peptide ingredient with three human clinical trials behind it. In a Maastricht University study published in The Journal of Nutrition, PeptiStrong outperformed milk protein on muscle protein synthesis during recovery. A second study in Nutrients showed significantly improved strength recovery, reduced muscle fatigue, and positive shifts in markers tied to muscle homeostasis. A third trial extended those benefits to women and showed gains in muscle strength, endurance, wellbeing, and bone mineral content.

Mechanically, it works through the mTOR and Phospho-S6 pathways — the same intracellular signaling that injectable peptides target — at a clinically validated 2.4g/day dose. It's the closest thing the supplement industry has to a true oral analog for what consumers are chasing with injectables, and it stacks well with creatine, leucine, and HMB.

PeptiSleep™ — Plant Peptides for Sleep Quality

PeptiSleep is a rice bran-derived peptide that supports sleep by lowering cortisol rather than forcing sedation the way melatonin does. In a randomized, double-blind, placebo-controlled clinical trial, participants saw improvements across all four domains of the Leeds Sleep Evaluation Questionnaire. Wearable data from the study showed 61% of participants fell asleep faster, with 17% more deep sleep, 13% more light sleep, and 35 additional minutes of total sleep on average.

It's clinically effective at 250mg/day, melatonin-free, and works in capsules, gummies, gels, beverages, and shots.

Why This Matters for Your Next Product

The injectable peptide story is what got consumers paying attention. Oral, clinically backed peptides are what brands can actually build a business on.

PeptiStrong and PeptiSleep give you both — the cell-signaling story consumers are excited about, and the safety, legality, and manufacturability you need to ship product at scale.

When you're ready to formulate, reach out for a free consultation. We'll talk needs, goals, costs, samples, and build you a no-pressure roadmap — including direct access to Nuritas ingredients and the formulation expertise to put them in a product that wins.

Your Next Move

Peptides are a growing category, and worth considering for your next product.

But success depends on partnering with a manufacturer who knows how to navigate the quality-control and technical nuances of peptide production. It’s not an easy format to get right. 

When the time is right, reach out for a free consultation. 

We’ll talk needs, goals, costs, samples, and provide a no-pressure roadmap developed by a manufacturing team that’s been there.

‍

Ben Steuart is the co-founder and CEO of Steuart Nutrition, a contract manufacturing and supplement innovation partner for powder, liquid, and stick‑pack supplements. He launched the company in 2019 alongside his wife, Sarah, building on his lifelong roots in the food production industry, where he grew up working in his father's manufacturing business in Mabel, Minnesota.

Throughout his career, Ben has developed deep expertise in supplement manufacturing and business operations. At Steuart, he leads with a commitment to lean operations, fostering long-term partnerships, and delivering flexible, transparent service—prioritizing the client’s vision as much as his own. His leadership guided the business’s rapid expansion to help several supplement brands double growth and expand into mass retail across the US.